A synopsis of the therapeutic trials of amezinium.
D015078:2-Hydroxyphenethylamine / Q000031:analogs & derivatives / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004087:Dihydroergotamine / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000188:drug therapy*; D009655:Octopamine / Q000031:analogs & derivatives*; D011724:Pyridazines / Q000009:adverse effects / Q000627:therapeutic use*
D011724:Pyridazines; D009655:Octopamine; D004087:Dihydroergotamine; D015078:2-Hydroxyphenethylamine; C005310:norfenefrine; C027784:amezinium